［1］Shcin OD, Munoz B, Tielah JM, et al. Prevalence of dry eye among the elderly［J］Am J Ophthalomol, 1997,124(6):723. ［2］Murube J, Paterson A, Murube E. Classification of artificial tears. I:Composition and properties［J］Adv Exp Med Biol, 1998,438:693. ［3］Aragona P, Papa V, Micali A, et al. Long term treatment with sodium hyaluronatecontaining artificial tears reduces ocular surface damage in patients with dry eye［J］Br J Ophthalmol, 2002, 86(2):181. ［4］Shimmura S, Ono M, Shinozaki K, et al. Sodium hyaluronate eyedrops in the treatment of dry eyes［J］Br J Ophthalmol, 1995,79(11):1007. ［5］Aragona P, Di Stefano G, Ferreri F, et al. Sodium hyaluronate eye drops of different osmolarity for the treatment of dry eye in Sjgren′s syndrome patients［J］Br J Ophthalmol, 2002,86(8):879. ［6］Pouliquen P. Carbomer gels in the treatment of dry eye［J］J Fr Ophthalmol, 1999,22(8):903. ［7］Bron AJ, Mangat H, Quinlan M, et al. Polyacrylic acid gel in patients with dry eyes:a randomised comparison with polyvinyl alcohol［J］Eur J Ophthalmol, 1998,8(2):81. ［8］Felt O, Carrel A, Baehni P, et al. Chitosan as tear substitute: a wetting agent endowed with antimicrobial efficacy［J］J Ocul Pharmacol Ther, 2000,16(3):261. ［9］Matsuo T, Tsuchida Y, Morimoto N. Trehalose eye drops in the treatment of dry eye syndrome［J］Ophthalmology, 2002, 109(11):2024. ［10］吴艺,张颖,王筠.中药人工泪液治疗Sjgren综合征患者干眼的疗效观察［J］. 中国中医眼科杂志, 2001,11(2):78. ［11］Biswas NR, Gupta SK, Das GK, et al. Evaluation of ophthacare eye drops—a herbal formulation in the management of various ophthalmic disorders［J］Phytother Res, 2001, 15(7):618. ［12］Stevenson D, Tauber J, Reis BL. Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderatetosevere dry eye disease:a doseranging, randomized trial. The Cyclosporin A Phase 2 Study Group［J］Ophthalmology, 2000,107(5):967. ［13］Marsh P, Pflugfelder SC. Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjgren syndrome［J］Ophthalmology, 1999,106(4):811. ［14］Sullivan DA, Sullivan BD, Evans JE, et al. Androgen deficiency, meibomian gland dysfunction, and evaporative dry eyes［J］Ann NY Acad Sci, 2002,966:211. ［15］Krenzer KL, Dana MR, Ullman MD, et al. Effect of androgen deficiency on the human meibomian gland and ocular surface［J］J Clin Endocrinol Metab, 2000,85(12):4874. ［16］McCulley JP, Shine WE. Meibomian gland and tear film lipids:structure, function and control［J］Adv Exp Med Biol, 2002,506(Pt A):373. ［17］Akramian J，Wedrich A, Nepp J, et al. Estrogen therapy in keratoconjunctivitis sicca［J］Adv Exp Med Biol, 1998,438:1005. ［18］Khurshudian AV. A pilot study to test the efficacy of oral administration of interferonalpha ozenges to patients with Sjgren′s syndrome［J］Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2003,95(1):38. ［19］Steinfeld SD, Demols P, van Vooren JP, et al. Zidovudine in primary Sjgren′s syndrome［J］Rheumatology (Oxford), 1999,38(9):814. ［20］Jumblatt JE, Cunningham LT, Li Y, et al. Characterization of human ocular mucin secretion mediated by 15(S)HETE［J］Cornea, 2002,21(8):818. ［21］Nagano T, Takeyama M. Enhancement of salivary secretion and neuropeptide (substance P, alphacalcitonin generelated peptide) levels in saliva by chronic anethole trithione treatment［J］J Pharmacol, 2001,53(12):1697. ［22］Shigemitsu T, Shimizu Y, Ishiguro K. Mucin ophthalmic solution treatment of dry eye［J］Adv Exp Med Biol, 2002,506(Pt A):359. ［23］Ogawa Y, Okamoto S, Mori T, et al. Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graftversushost disease［J］Bone Marrow Transplant, 2003,31(7):579.